MedPage Today on MSN
New TYK2 inhibitors for psoriasis achieve high clearance rates in randomized trials
Three-fourths of patients have 70-75% improvement at 16 weeks with zasocitinib, envudeucit ...
An open-label, multicenter, phase 1/2 study of peluntamig (PT217), an anti-DLL3/anti-CD47 bispecific antibody, in patients with DLL3-expressing cancers such as SCLC, LCNEC and EP-NEC (SKYBRIDGE study) ...
Whole-blood transfusion has recently gained favor in the management of severe hemorrhage; however, data from large clinical trials evaluating its clinical effectiveness and safety are lacking. We ...
In what is believed to be the first randomized placebo-controlled trial of its kind, patients with a chronic total blockage ...
The European Randomized Study of Screening for Prostate Cancer (ERSPC) was initiated in 1993 to assess the effect of prostate-specific antigen (PSA) testing on prostate cancer mortality. Because ...
SALVOVAR: A pragmatic randomized phase III trial comparing the salvage weekly dose-dense regimen to the standard 3-weekly regimen in patients with poor prognostic ovarian cancers (GINECO-OV130b; ENGOT ...
Providence Medical Technology’s latest randomized controlled trial is designed to once again challenge the standard of care ...
A new randomized clinical trial from Mass General Brigham researchers highlights a promising digital approach to mental ...
BACKGROUND: Medically tailored meals (MTM) have unanswered implementation questions. Providing MTM for a specific individual, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results